Unfortunately, the graph for the number of operations doesn't paint a similar rosey picture. By reading the announcement it confirms why the last quarter was so poor for revenue. From memory the number of operations has gone from 600, to 1000 and now back to 400 over the last three quarters. With the imminent CR, plus the consolidation, it really leaves this stock with absolute no room to breath. Management need to step up and explain what the plan forward is and try forecast the hiccups ahead like the current quarter (which it hopefully is just that), so that holders have clarity and to dampen any future shocks to expectations.
- Forums
- ASX - By Stock
- Ann: Admedus achieves label expansion for CardioCel in Europe
Unfortunately, the graph for the number of operations doesn't...
- There are more pages in this discussion • 132 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.30 |
Change
0.250(1.31%) |
Mkt cap ! $372.9M |
Open | High | Low | Value | Volume |
$19.05 | $19.50 | $18.90 | $93.58K | 4.855K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $19.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.30 | 20 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 419 | 19.150 |
1 | 32 | 19.110 |
1 | 250 | 19.100 |
1 | 36 | 19.030 |
1 | 140 | 19.020 |
Price($) | Vol. | No. |
---|---|---|
19.300 | 20 | 1 |
19.460 | 150 | 1 |
19.500 | 2909 | 3 |
19.800 | 1000 | 1 |
19.990 | 6000 | 1 |
Last trade - 15.28pm 12/06/2024 (20 minute delay) ? |
|
|||||
Last
$19.39 |
  |
Change
0.250 ( 2.05 %) |
|||
Open | High | Low | Volume | ||
$19.00 | $19.39 | $19.00 | 224 | ||
Last updated 11.17am 12/06/2024 ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online